Increased fracture incidence in middle-aged HIV-infected and HIV-uninfected women: Updated results from the women's interagency HIV study

Journal of Acquired Immune Deficiency Syndromes

Volumn 70, Issue 1, 2015, Pages 54-61

  Sharma, Anjali ^a   Shi, Qiuhu ^b   Hoover, Donald R ^c   Anastos, Kathryn ^a   Tien, Phyllis C ^d   Young, Mary A ^e   Cohen, Mardge H ^f   Golub, Elizabeth T ^g   Gustafson, Deborah ^h   Yin, Michael T ⁱ  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c RUTGERS UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f RUSH MEDICAL COLLEGE   (United States)

^g JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^h SUNY DOWNSTATE MEDICAL CENTER   (United States)

ⁱ NewYork Presbyterian Hospital   (United States)

Author keywords

bone; fracture; fragility fracture; HIV; women

Indexed keywords

CALCIUM; COCAINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; VITAMIN D;

ADULT; ALCOHOL CONSUMPTION; ANKLE FRACTURE; BODY WEIGHT; CAUCASIAN; CD4 LYMPHOCYTE COUNT; CLAVICLE FRACTURE; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE SEVERITY; DRUG USE; ELBOW FRACTURE; FEMALE; FOLLOW UP; FOOT FRACTURE; FRACTURE; FRAGILITY FRACTURE; HAND FRACTURE; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIP FRACTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; KNEE FRACTURE; LEG FRACTURE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NOSE FRACTURE; PELVIS FRACTURE; POSTMENOPAUSE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RIB FRACTURE; SELF REPORT; SHOULDER FRACTURE; SMOKING; SPINE FRACTURE; WRIST FRACTURE; CLINICAL TRIAL; COMPLICATION; FRACTURES, BONE; MIDDLE AGED; RISK FACTOR;

ADULT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; FRACTURES, BONE; HIV INFECTIONS; HUMANS; INCIDENCE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 84939813036     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000674     Document Type: Conference Paper

References (31)

1. Brown TT, Qaqish RB. Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-Analytic review. AIDS. 2006; 20: 2165-2174
2. Cazanave C, Dupon M, Lavignolle-Aurillac V, et al. Reduced bone mineral density in HIV-infected patients: prevalence and associated factors. AIDS. 2008; 22: 395-402
3. Dolan SE, Kanter JR, Grinspoon S. Longitudinal analysis of bone density in human immunodeficiency virus-infected women. J Clin Endocrinol Metab. 2006; 91: 2938-2945
4. Mondy K, Yarasheski K, Powderly WG, et al. Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals. Clin Infect Dis. 2003; 36: 482-490
5. Bolland MJ, Grey AB, Gamble GD, et al. Clinical Review: low body weight mediates the relationship between HIV infection and low bone mineral density: a meta-Analysis. J Clin Endocrinol Metab. 2007; 92: 4522-4528
6. Fakruddin JM, Lawerence J. HIV-1 Vpr enhances production of activated NF-kappaB ligand (RANKL) via potentiation of glucocorticoid receptor activity. Arch Virol. 2005; 150: 67-78
7. Gibellini D, de Crignis E, Ponti C, et al. HIV-1 triggers apoptosis in primary osteoblasts and HOBIT cells through TNFalpha activation. J Med Virol. 2008; 80: 1507-1514
8. Brown TT, McComsey GA, King MS, et al. Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen. J Acquir Immune Defic Syndr. 2009; 51: 554-561
9. Cassetti I, Madruga JV, Suleiman JM, et al; Study 903E Team The safety and efficacy of tenofovir DF in combination with lamivudine and efavirenz through 6 years in antiretroviral-naïve HIV-1-infected patients. HIV Clin Trials. 2007; 8: 164-172
10. Duvivier C, Kolta S, Assoumou L, et al. Greater decrease in bone mineral density with protease inhibitor regimens compared with nonnucleoside reverse transcriptase inhibitor regimens in HIV-1 infected naive patients. AIDS. 2009; 23: 817-824
11. Finkelstein JS, Brockwell SE, Mehta V, et al. Bone mineral density changes during the menopause transition in a multiethnic cohort of women. J Clin Endocrinol Metab. 2008; 93: 861-868
12. Yin MT, Lu D, Cremers S, et al. Short-Term bone loss in HIV-infected premenopausal women. J Acquir Immune Defic Syndr. 2010; 53: 202-208
13. Grund B, Peng G, Gibert CL, et al. Continuous antiretroviral therapy decreases bone mineral density. AIDS. 2009; 23: 1519-1529
14. Hansen AB, Gerstoft J, Kronborg G, et al. Incidence of low and highenergy fractures in persons with and without HIV infection: a Danish population-based cohort study. AIDS. 2012; 26: 285-293
15. Young B, Dao CN, Buchacz K, et al; HIV Outpatient Study (HOPS) Investigators. Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000-2006. Clin Infect Dis. 2011; 52: 1061-1068
16. Womack JA, Goulet JL, Gibert C, et al; Veterans Aging Cohort Study Project Team. Increased risk of fragility fractures among HIV infected compared to uninfected male veterans. PLoS One. 2011; 6: e17217
17. Yin MT, Shi Q, Hoover DR, et al. Fracture incidence in HIV-infected women: results from the Womens Interagency HIV Study. AIDS. 2010; 24: 2679-2686
18. Arnsten JH, Freeman R, Howard AA, et al. Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection. AIDS. 2007; 21: 617-623
19. Collin F, Duval X, Le Moing V, et al. Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults. AIDS. 2009; 23: 1021-1024
20. Bacon MC, von Wyl V, Alden C, et al. The Womens Interagency HIV study: an observational cohort brings clinical sciences to the bench. Clin Diagn Lab Immunol. 2005; 12: 1013-1019
21. Mackey DC, Lui LY, Cawthon PM, et al. High-Trauma fractures and low bone mineral density in older women and men. JAMA. 2007; 298: 2381-2388
22. Kanis JA, McCloskey EV, Johansson H, Oden A, Strom O, Borgstrom F. Development and use of FRAX in osteoporosis. Osteoporosis Int. 2010; 21(Suppl 2): S407-S413
23. Levey AS, Bosch JP, Lewis JB, et al A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999; 130: 461-470
24. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. 2nd ed. Hoboken, NJ: Wiley; 2002
25. Mundy LM, Youk AO, McComsey GA, et al. Overall benefit of antiretroviral treatment on the risk of fracture in HIV: nested case-control analysis in a health-insured population. AIDS. 2012; 26: 1073-1082
26. Prieto-Alhambra D, Güerri-Fernández R, De Vries F, et al. HIV infection and its association with an excess risk of clinical fractures: a nationwide case-control study. J Acquir Immune Defic Syndr. 2014; 66: 90-95
27. Yong MK, Elliott JH, Woolley IJ, et al. Low CD4 count is associated with an increased risk of fragility fracture in HIV-infected patients. J Acquir Immune Defic Syndr. 2011; 57: 205-210
28. Güerri-Fernandez R, Vestergaard P, Carbonell C, et al. HIV infection is strongly associated with hip fracture risk, independently of age, gender, and comorbidities: a population-based cohort study. J Bone Miner Res. 2013; 28: 1259-1263
29. Erlandson KM, Allshouse AA, Jankowski CM, et al. Risk factors for falls in HIV-infected persons. J Acquir Immune Defic Syndr. 2012; 61: 484-489
30. Maalouf NM, Zhang S, Drechsler H, et al. Hepatitis C co-infection and severity of liver disease as risk factors for osteoporotic fractures among HIV-infected patients. J Bone Miner Res. 2013; 28: 2577-2583
31. Yin MT, Kendall MA, Wu X, et al. Fractures after antiretroviral initiation. AIDS. 2012; 26: 2175-2184